Research Objective To evaluate the efficacy, safety, and therapeutic effect of topical cyclosporin A 0.05% as a steroid sparing agent in steroid-dependent allergic conjunctivitis. Study Design Prospective, randomized, double masked, placebo-controlled trial. Level of Evidence: I Location Centre for Eye Research Australia, University of Melbourne and Corneal Clinic, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.
展开▼
